# Pharmacokinetic and Safety Study of HYR-PB21 vs Bupivacaine Hydrochloric Acid in Healthy Participants

> **NCT07717086** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Fruithy Holdings Limited** · enrollment: 28 (estimated)

## Conditions studied

- Postoperative Analgesia

## Interventions

- **DRUG:** HYR-PB21， 100 mg
- **DRUG:** HYR-PB21， 200 mg
- **DRUG:** HYR-PB21， 400 mg
- **DRUG:** Bupivacaine hydrochloride， 100 mg (as base)

## Key facts

- **NCT ID:** NCT07717086
- **Lead sponsor:** Fruithy Holdings Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08
- **Primary completion:** 2026-09
- **Final completion:** 2026-10
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2026-08-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07717086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07717086, "Pharmacokinetic and Safety Study of HYR-PB21 vs Bupivacaine Hydrochloric Acid in Healthy Participants". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07717086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*